Investigational Site Number 840017

Philadelphia, Pennsylvania 19111

0 studies enrolling now · 1 studies all time

What they study most

Neoplasm Malignant

Studies at this site

• Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen — Completed